In addition, enzymatic interfereance by blocking VASH1 or activating TTL effectively decreases stiffness and increases relaxation speed in failing cardiomyocytes of heart failure patients without markedly affecting the intracellular calcium transient in the failing cardiomyocytes of heart failure patients (Chen et al., 2020). This evidence concerns the gene VASH1 and heart failure.